{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:48:21Z","timestamp":1776919701477,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancers are driven by a variety of somatic gene mutations and identifying these mutations enables the development of novel target drugs. We have sought to identify abnormalities in Wnt pathway-related genes that are sensitive to Wnt inhibitor treatment. We examined Patient Derived Xenograft (PDX) RNA samples and found new R-Spondin 2 (RSPO2) transcript fusions with the EMC2, PVT1 or HNF4G genes. These fusion events were identified in about 1.4% of the digestive system cancer samples. We then examined the oncogenic effects of the RSPO2-EMC2 fusion gene and confirmed that it can drive oncogenesis, sustain tumor growth and promote metastasis. Finally, we used a Wnt pathway Porcupine inhibitor CGX1321 to treat PDX mouse models containing RSPO2 fusion genes. All the RSPO2 fusion tumors responded to the treatment and stopped progression. Our data show that Wnt pathway inhibition could provide an effective treatment for cancers containing RSPO2 fusion. The RSPO2 fusion will serve as a good biomarker for screening patients to support clinical treatment of digestive system cancers using Wnt pathway inhibitors.<\/jats:p>","DOI":"10.1038\/s41598-018-32652-3","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:38:37Z","timestamp":1537263517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor"],"prefix":"10.1038","volume":"8","author":[{"given":"Chong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5302-6392","authenticated-orcid":false,"given":"Yuhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"32652_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480, https:\/\/doi.org\/10.1016\/j.cell.2006.10.018 (2006).","journal-title":"Cell"},{"key":"32652_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat Med 10, 789\u2013799, https:\/\/doi.org\/10.1038\/nm1087 (2004).","journal-title":"Nat Med"},{"key":"32652_CR3","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"S Monga","year":"2015","unstructured":"Monga, S. P. beta-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology 148, 1294\u20131310, https:\/\/doi.org\/10.1053\/j.gastro.2015.02.056 (2015).","journal-title":"Gastroenterology"},{"key":"32652_CR4","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/j.cellsig.2014.08.023","volume":"26","author":"K Fan","year":"2014","unstructured":"Fan, K. et al. Wnt\/beta-catenin signaling induces the transcription of cystathionine-gamma-lyase, a stimulator of tumor in colon cancer. Cell Signal 26, 2801\u20132808, https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.023 (2014).","journal-title":"Cell Signal"},{"key":"32652_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature22081","volume":"545","author":"M Shimokawa","year":"2017","unstructured":"Shimokawa, M. et al. Visualization and targeting of LGR5+ human colon cancer stem cells. Nature 545, 187\u2013192, https:\/\/doi.org\/10.1038\/nature22081 (2017).","journal-title":"Nature"},{"key":"32652_CR6","doi-asserted-by":"publisher","first-page":"djt356","DOI":"10.1093\/jnci\/djt356","volume":"106","author":"DJ Stewart","year":"2014","unstructured":"Stewart, D. J. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 106, djt356, https:\/\/doi.org\/10.1093\/jnci\/djt356 (2014).","journal-title":"J Natl Cancer Inst"},{"key":"32652_CR7","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1038\/sj.onc.1206817","volume":"22","author":"K Uematsu","year":"2003","unstructured":"Uematsu, K. et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22, 7218\u20137221, https:\/\/doi.org\/10.1038\/sj.onc.1206817 (2003).","journal-title":"Oncogene"},{"key":"32652_CR8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.1071549","volume":"296","author":"RT Moon","year":"2002","unstructured":"Moon, R. T., Bowerman, B., Boutros, M. & Perrimon, N. The promise and perils of Wnt signaling through beta-catenin. Science 296, 1644\u20131646, https:\/\/doi.org\/10.1126\/science.1071549 (2002).","journal-title":"Science"},{"key":"32652_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","volume":"5","author":"MT Veeman","year":"2003","unstructured":"Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon: Functions and mechanisms of beta-catenin-independent wnt signaling. Dev Cell 5, 367\u2013377, https:\/\/doi.org\/10.1016\/S1534-5807(03)00266-1 (2003).","journal-title":"Dev Cell"},{"key":"32652_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev.cellbio.14.1.59","volume":"14","author":"A Wodarz","year":"1998","unstructured":"Wodarz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Bi 14, 59\u201388, https:\/\/doi.org\/10.1146\/annurev.cellbio.14.1.59 (1998).","journal-title":"Annu Rev Cell Dev Bi"},{"key":"32652_CR11","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1242\/dev.01318","volume":"131","author":"F Cong","year":"2004","unstructured":"Cong, F., Schweizer, L. & Varmus, H. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 131, 5103\u20135115, https:\/\/doi.org\/10.1242\/dev.01318 (2004).","journal-title":"Development"},{"key":"32652_CR12","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1634\/stemcells.2005-0503","volume":"24","author":"P Neth","year":"2006","unstructured":"Neth, P. et al. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 24, 1892\u20131903, https:\/\/doi.org\/10.1634\/stemcells.2005-0503 (2006).","journal-title":"Stem Cells"},{"key":"32652_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jcb.20400","volume":"95","author":"K Mi","year":"2005","unstructured":"Mi, K. & Johnson, G. V. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. J Cell Biochem 95, 328\u2013338, https:\/\/doi.org\/10.1002\/jcb.20400 (2005).","journal-title":"J Cell Biochem"},{"key":"32652_CR14","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1038\/onc.2014.416","volume":"34","author":"E Lemieux","year":"2015","unstructured":"Lemieux, E., Cagnol, S., Beaudry, K., Carrier, J. & Rivard, N. Oncogenic KRAS signalling promotes the Wnt\/beta-catenin pathway through LRP6 in colorectal cancer. Oncogene 34, 4914\u20134927, https:\/\/doi.org\/10.1038\/onc.2014.416 (2015).","journal-title":"Oncogene"},{"issue":"12","key":"32652_CR15","doi-asserted-by":"publisher","first-page":"a007880","DOI":"10.1101\/cshperspect.a007880","volume":"4","author":"B. T. MacDonald","year":"2012","unstructured":"MacDonald, B. T. & He, X. Frizzled and LRP5\/6 receptors for Wnt\/beta-catenin signaling. Cold Spring Harb Perspect Biol 4, https:\/\/doi.org\/10.1101\/cshperspect.a007880 (2012).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"32652_CR16","doi-asserted-by":"publisher","first-page":"R592","DOI":"10.1016\/S0960-9822(01)00360-8","volume":"11","author":"AM Zorn","year":"2001","unstructured":"Zorn, A. M. Wnt signalling: Antagonistic Dickkopfs. Curr Biol 11, R592\u2013R595, https:\/\/doi.org\/10.1016\/S0960-9822(01)00360-8 (2001).","journal-title":"Curr Biol"},{"key":"32652_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.devcel.2004.07.019","volume":"7","author":"O Kazanskaya","year":"2004","unstructured":"Kazanskaya, O. et al. R-Spondin2 is a secreted activator of Wnt\/beta-catenin signaling and is required for Xenopus myogenesis. Dev Cell 7, 525\u2013534, https:\/\/doi.org\/10.1016\/j.devcel.2004.07.019 (2004).","journal-title":"Dev Cell"},{"key":"32652_CR18","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/emboj.2012.149","volume":"31","author":"J Schuijers","year":"2012","unstructured":"Schuijers, J. & Clevers, H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J 31, 2685\u20132696, https:\/\/doi.org\/10.1038\/emboj.2012.149 (2012).","journal-title":"EMBO J"},{"key":"32652_CR19","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1073\/pnas.1106083108","volume":"108","author":"KS Carmon","year":"2011","unstructured":"Carmon, K. S., Gong, X., Lin, Q., Thomas, A. & Liu, Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/beta-catenin signaling. Proc Natl Acad Sci USA 108, 11452\u201311457, https:\/\/doi.org\/10.1073\/pnas.1106083108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"32652_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3787","volume":"4","author":"M Zebisch","year":"2013","unstructured":"Zebisch, M. et al. Structural and molecular basis of ZNRF3\/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 4, 2787, https:\/\/doi.org\/10.1038\/ncomms3787 (2013).","journal-title":"Nat Commun"},{"key":"32652_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao, H. X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195\u2013200, https:\/\/doi.org\/10.1038\/nature11019 (2012).","journal-title":"Nature"},{"key":"32652_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau, W., Peng, W. C., Gros, P. & Clevers, H. The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28, 305\u2013316, https:\/\/doi.org\/10.1101\/gad.235473.113 (2014).","journal-title":"Genes Dev"},{"key":"32652_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature11282","volume":"488","author":"S Seshagiri","year":"2012","unstructured":"Seshagiri, S. et al. Recurrent R-spondin fusions in colon cancer. Nature 488, 660\u2013664, https:\/\/doi.org\/10.1038\/nature11282 (2012).","journal-title":"Nature"},{"key":"32652_CR24","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1007\/s11033-014-3409-x","volume":"41","author":"K Shinmura","year":"2014","unstructured":"Shinmura, K. et al. RSPO fusion transcripts in colorectal cancer in Japanese population. Mol Biol Rep 41, 5375\u20135384, https:\/\/doi.org\/10.1007\/s11033-014-3409-x (2014).","journal-title":"Mol Biol Rep"},{"key":"32652_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15704-y","volume":"7","author":"MM Fischer","year":"2017","unstructured":"Fischer, M. M. et al. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations. Sci Rep 7, 15270, https:\/\/doi.org\/10.1038\/s41598-017-15704-y (2017).","journal-title":"Sci Rep"},{"key":"32652_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature16466","volume":"529","author":"EE Storm","year":"2016","unstructured":"Storm, E. E. et al. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function. Nature 529, 97\u2013100, https:\/\/doi.org\/10.1038\/nature16466 (2016).","journal-title":"Nature"},{"key":"32652_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/his.13265","volume":"71","author":"S Sekine","year":"2017","unstructured":"Sekine, S. et al. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas. Histopathology 71, 601\u2013609, https:\/\/doi.org\/10.1111\/his.13265 (2017).","journal-title":"Histopathology"},{"key":"32652_CR28","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H. & Nusse, R. Wnt\/beta-catenin signaling and disease. Cell 149, 1192\u20131205, https:\/\/doi.org\/10.1016\/j.cell.2012.05.012 (2012).","journal-title":"Cell"},{"key":"32652_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn, M. Can we safely target the WNT pathway? Nat Rev Drug Discov 13, 513\u2013532, https:\/\/doi.org\/10.1038\/nrd4233 (2014).","journal-title":"Nat Rev Drug Discov"},{"key":"32652_CR30","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","volume":"109","author":"A Gurney","year":"2012","unstructured":"Gurney, A. et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA 109, 11717\u201311722, https:\/\/doi.org\/10.1073\/pnas.1120068109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"32652_CR31","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci USA 110, 20224\u201320229, https:\/\/doi.org\/10.1073\/pnas.1314239110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"32652_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas, J. N. & Moon, R. T. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13, 11\u201326, https:\/\/doi.org\/10.1038\/nrc3419 (2013).","journal-title":"Nat Rev Cancer"},{"key":"32652_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nchembio.137","volume":"5","author":"B Chen","year":"2009","unstructured":"Chen, B. et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5, 100\u2013107, https:\/\/doi.org\/10.1038\/nchembio.137 (2009).","journal-title":"Nat Chem Biol"},{"key":"32652_CR34","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1021\/acs.jmedchem.5b00507","volume":"58","author":"AJ Duraiswamy","year":"2015","unstructured":"Duraiswamy, A. J. et al. Discovery and Optimization of a Porcupine Inhibitor. Journal of medicinal chemistry 58, 5889\u20135899, https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00507 (2015).","journal-title":"Journal of medicinal chemistry"},{"key":"32652_CR35","doi-asserted-by":"publisher","first-page":"12649","DOI":"10.1073\/pnas.1307218110","volume":"110","author":"X Jiang","year":"2013","unstructured":"Jiang, X. et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA 110, 12649\u201312654, https:\/\/doi.org\/10.1073\/pnas.1307218110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"32652_CR36","unstructured":"C., K. S., Xing, G., Qiushi, L., Anthony, T. & Qingyun, L. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/\u03b2-catenin signaling (2011)."},{"key":"32652_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ijc.20361","volume":"112","author":"M Menendez","year":"2004","unstructured":"Menendez, M. et al. Colorectal cancer risk and the APC D1822V variant. Int J Cancer 112, 161\u2013163, https:\/\/doi.org\/10.1002\/ijc.20361 (2004).","journal-title":"Int J Cancer"},{"key":"32652_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ol.2014.2102","volume":"8","author":"M Feng","year":"2014","unstructured":"Feng, M. et al. Association between the APC gene D1822V variant and the genetic susceptibility of colorectal cancer. Oncol Lett 8, 139\u2013144, https:\/\/doi.org\/10.3892\/ol.2014.2102 (2014).","journal-title":"Oncol Lett"},{"issue":"27","key":"32652_CR39","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1073\/pnas.1221926110","volume":"110","author":"K. Onuma","year":"2013","unstructured":"Kunishige Onuma, M. O. et al. Genetic reconstitution of tumorigenesis in primary intestinal cells (2013).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"32652_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss, G. K. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26, 317\u2013325, https:\/\/doi.org\/10.1038\/nbt1385 (2008).","journal-title":"Nat Biotechnol"},{"key":"32652_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jso.2930310402","volume":"31","author":"DM Euhus","year":"1986","unstructured":"Euhus, D. M., Hudd, C., LaRegina, M. C. & Johnson, F. E. Tumor measurement in the nude mouse. J Surg Oncol 31, 229\u2013234 (1986).","journal-title":"J Surg Oncol"},{"key":"32652_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24, 148\u2013154 (1989).","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32652-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:56:14Z","timestamp":1671616574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32652"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32652-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14244"}}